CATT: Visual acuity gains not maintained at 5 years in AMD patients

Visual gains attained at 2 years were not sustained at 5 years in patients with neovascular age-related macular degeneration who were treated with anti-VEGFs, according to follow-up data from the Comparison of Age-Related Macular Degeneration Treatment Trials.Follow-up data were published in Ophthalmology and discussed at the Association for Research in Vision and Ophthalmology meeting in Seattle.